Certara, Inc. Logo

Certara, Inc.

Accelerates drug development using biosimulation software, technology, and services.

CERT | US

Overview

Corporate Details

ISIN(s):
US15687V1098
LEI:
Country:
United States of America
Address:
4 RADNOR CORPORATE CENTER, SUITE 350, 19087 RADNOR

Description

Certara, Inc. is a company that accelerates drug discovery and development through the use of proprietary biosimulation software, technology, and expert services. It provides an end-to-end platform that supports clients across the entire drug development lifecycle, from discovery and preclinical research to clinical trials, regulatory submissions, and market access. The company's solutions leverage predictive simulation, data-driven modeling, and advanced analytics to help pharmaceutical and biotechnology organizations optimize trial design, justify dosing decisions, and navigate regulatory requirements. Key software products include Simcyp, Phoenix, and Pinnacle 21. Certara's offerings are designed to de-risk development, enhance efficiency, and increase the likelihood of bringing new medicines to patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all Certara, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Certara, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Certara, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Ceres Power Holdings PLC Logo
A developer of solid oxide technology for clean power and green hydrogen production.
United Kingdom
CWR
CervoMed Inc. Logo
A clinical-stage biotech developing treatments for age-related neurologic disorders.
United States of America
CRVO
Chabiotech Co.,Ltd. Logo
Develops cell/gene therapies and provides CDMO and bio-banking services.
South Korea
085660
CHAMPIONS ONCOLOGY, INC. Logo
A CRO providing end-to-end solutions to accelerate oncology drug development.
United States of America
CSBR
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Logo
A contract research organization supporting drug discovery and development.
United States of America
CRL
Chiome Bioscience Inc. Logo
Clinical-stage biotech company developing antibody-based therapeutics.
Japan
4583
Chordate Medical Holding AB Logo
Develops a patented, drug-free neuromodulation treatment for migraine and rhinitis.
Sweden
CMH
Chordia Therapeutics,Inc Logo
Clinical-stage biotech developing novel cancer therapies targeting RNA deregulation.
Japan
190A
Cibus, Inc. Logo
Develops and licenses plant traits using non-GMO precision gene-editing technology.
United States of America
CBUS
Circio Holding ASA Logo
Clinical-stage company developing circular RNA medicines and immunotherapies.
Norway
CRNA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.